Evidence map›Paper›PMID 33417828›Full record

ArticleCell chemical biology2021

Proteomics of broad deubiquitylase inhibition unmasks redundant enzyme function to reveal substrates and assess enzyme specificity.

Valentina Rossio, Joao A Paulo, Joel Chick, Bradley Brasher, Steven P Gygi, Randall W King

Open access · bronzeAbstract read
In one paragraph

Article in Cell chemical biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Identification of Deubiquitinase Substrates in Xenopus Egg Extract.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  7. Article
  8. FeJournal of proteomics · 2022
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Valentina RossioDepartment of Cell Biology, Blavatnik Institute at Harvard Medical School, Boston, MA 02115, USA.
Joao A PauloDepartment of Cell Biology, Blavatnik Institute at Harvard Medical School, Boston, MA 02115, USA.
Joel ChickDepartment of Cell Biology, Blavatnik Institute at Harvard Medical School, Boston, MA 02115, USA.
Bradley BrasherBoston Biochem, a Bio-Techne Brand, Cambridge, MA 02139, USA.
Steven P GygiDepartment of Cell Biology, Blavatnik Institute at Harvard Medical School, Boston, MA 02115, USA.
Randall W KingDepartment of Cell Biology, Blavatnik Institute at Harvard Medical School, Boston, MA 02115, USA. Electronic address: randy_king@hms.harvard.edu.
Harvard University · USR&D Systems (United States) · US

Funding

New Sample Multiplexing Technologies to Identify Chemical Probes and Illuminate Ubiquitin BiologyR01GM067945 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI GYGI, STEVEN P · 2003 to 2024
$10.5M
Mechanistic Analysis of the Ubiquitin-Proteasome SystemR35GM127032 · NIGMS · HARVARD MEDICAL SCHOOL · PI RANDALL W KING · 2018 to 2026
$4.0M
Advancing Multiplexed Isobaric Tag-based Strategies for Proteome ProfilingR01GM132129 · NIGMS · HARVARD MEDICAL SCHOOL · PI PAULO, JOAO A · 2019 to 2023
$1.7M
NIGMS NIH HHS R01 GM067945NIGMS NIH HHS R01 GM132129NIGMS NIH HHS R35 GM127032
6 · The paper itself

Abstract

Deubiquitylating enzymes (DUBs) counteract ubiquitylation to control stability or activity of substrates. Identification of DUB substrates is challenging because multiple DUBs can act on the same substrate, thwarting genetic approaches. Here, we circumvent redundancy by chemically inhibiting multiple DUBs simultaneously in Xenopus egg extract. We used quantitative mass spectrometry to identify proteins whose ubiquitylation or stability is altered by broad DUB inhibition, and confirmed their DUB-dependent regulation with human orthologs, demonstrating evolutionary conservation. We next extended this method to profile DUB specificity. By adding recombinant DUBs to extract where DUB activity was broadly inhibited, but ubiquitylation and degradation were active at physiological rates, we profiled the ability of DUBs to rescue degradation of these substrates. We found that USP7 has a unique ability to broadly antagonize degradation. Together, we present an approach to identify DUB substrates and characterize DUB specificity that overcomes challenges posed by DUB redundancy.

Indexed as

ProteomicsEnzyme InhibitorsHumansPyrrolesSubstrate SpecificityUbiquitinationUbiquitin-Specific Peptidase 7Enzyme InhibitorsIU1-47PyrrolesUbiquitin-Specific Peptidase 7USP7 protein, humandeubiquitylating enzymesproteasomal degradationTMT-proteomicsubiquitinUPS substratesUSP7Xenopus

Identifiers

PMID33417828
PMCPMC8052291
OpenAlexW3120197834

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.